Enabling Technologies for Design and Delivery of Novel Vaccines Against Infectious Diseases and Cancer.

用于设计和交付针对传染病和癌症的新型疫苗的支持技术。

• 批准号: nhmrc : 1042018
• 负责人: Prof David Jackson
• 金额: $ 61.7万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/enabling-technologies-design-diseases-cancer/111428
• 关键词: Enabling; Technologies; Design; Delivery; Novel

This grant will support research necessary to develop the next generation of vaccines. These will combat diseases caused by bacteria and viruses and can also be used to fight cancer. The broad range of application is made possible through the incorporation of simple molecular features that activate the immune system. The intellectual property that has been developed is protected by a patent portfolio some patents of which are already licenced to the pharmaceutical industry.

这笔赠款将支持开发下一代疫苗所需的研究。这些将对抗由细菌和病毒引起的疾病，也可用于对抗癌症。通过结合激活免疫系统的简单分子特征，使广泛的应用成为可能。已开发的知识产权受到专利组合的保护，其中一些专利已被许可给制药业。